Retatrutide Peptide

Research use only · Not FDA/EMA approved · Details

Author

The editorial desk

One editorial desk signs every article, run by OX RESEARCH LTD, the company behind OXpeptides.

Published 23 Sep 20263 min read0 sources
Three sealed retatrutide vials from OXpeptides, research use only, on a white background.

Who the desk is

The desk is the editorial team of OX RESEARCH LTD, a company registered under number 17464288. The same company runs OXpeptides, a shop that sells research-use-only peptides, retatrutide among them. That is a direct interest, and every page of this site states it in the footer.

It publishes under one collective name instead of a person. We do not invent a writer, a biography or a qualification, and no physician or pharmacist signs the articles. Nothing on this site is medical advice. Retatrutide is investigational and not approved by the FDA or the EMA.

What the desk reads

Trial results come from three kinds of source. Peer-reviewed papers are cited by DOI. Trial registry records on ClinicalTrials.gov are cited by NCT number. Phase 3 topline results that Eli Lilly has announced but not yet published are cited by the URL of the press release and labelled as such. News articles are never used as the source of a number.

How it checks

Before an article goes up, and again at each update, every DOI is resolved against the CrossRef API and every NCT number against the ClinicalTrials.gov API v2. A source that fails to resolve is removed, together with the claim it supported. Doses appear only as the protocol of a cited trial. Discussion of online forums describes patterns of claims without quoting or naming anyone. You will find the full rules in the editorial policy and the method on the about page.

Its link with OXpeptides

Each article carries one link to the retatrutide page at OXpeptides, and the vendor comparison on the home page places OXpeptides first on a grid whose criteria are printed next to it. There is no advertising and no affiliate link on the site. The trial figures do not depend on who publishes them, and each one links to its paper or registry record so you can check it.

Articles signed by the desk

4 pages are published and indexed today. Each shows its own publication and update dates.

Contact and corrections

Write to editor@retatrutide-peptide.com with the page URL and the figure that looks wrong. When a correction is made, the page and its update date change, and substantive corrections are noted at the bottom of the article.